ResMed Financial Ratios
RMD / Health Care|FY2025 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2025 SEC 10-K data.
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 3.25 (safe zone, above 2.9 threshold)
- Strong profit margin: 27.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2025)
Return on Equity
23.5%
Profit Margin
27.2%
Net Income / Revenue
Asset Turnover
0.63
Revenue / Total Assets
Equity Multiplier
1.37
Total Assets / Equity
Composite: 23.5% (reported: 23.5%)
Profitability
Liquidity
Current Ratio
3.44
Quick Ratio
2.53
Solvency
Interest Coverage
-
Efficiency
Asset Turnover
0.63
Inventory Turnover
2.25
Days Sales Outstanding
67 days
As of FY2025 · SEC 10-K · Updated Feb 28, 2026
Earnings Quality
Accrual Ratio
-4.7%
+0.9pp YoY
Earnings are primarily supported by operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.